Technical Analysis for ADMA - ADMA Biologics Inc

Grade Last Price % Change Price Change
F 1.68 -2.89% -0.05
ADMA closed up 0.58 percent on Thursday, April 15, 2021, on 77 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical ADMA trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup -2.89%
Doji - Bullish? Reversal -2.89%
Wide Bands Range Expansion -2.89%
Boomer Sell Setup Bearish Swing Setup -2.33%
Wide Bands Range Expansion -2.33%
180 Bearish Setup Bearish Swing Setup -1.75%
Inside Day Range Contraction -1.75%
Wide Bands Range Expansion -1.75%
Doji - Bullish? Reversal -5.62%
Wide Bands Range Expansion -5.62%
Older End-of-Day Signals for ADMA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% about 3 hours ago
Down 3% about 3 hours ago
Down 2 % about 3 hours ago
Down 1% about 3 hours ago
Fell Below Previous Day's Low about 3 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ADMA Biologics, Inc., a late stage biopharmaceutical company, develops, manufactures, and intends to market plasma-based biologics for the treatment and prevention of infectious diseases. Its lead product candidate, RI-002, which is in Phase III clinical trial, is intended for the treatment of primary immune deficiency disease. RI-002 is an injectable immune globulin derived from human plasma enriched with high levels of naturally occurring polyclonal antibodies, as well as high levels of antibodies targeted to respiratory syncytial virus. The company also operates ADMA BioCenters, which are plasma collection centers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Biology Pharmaceutical Industry Immunology Immune System Infectious Diseases Antibodies Antibody Glycoproteins Late Stage Biopharmaceutical

Is ADMA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.2
52 Week Low 1.572
Average Volume 3,315,674
200-Day Moving Average 2.35
50-Day Moving Average 2.21
20-Day Moving Average 1.86
10-Day Moving Average 1.78
Average True Range 0.13
ADX 39.16
+DI 9.02
-DI 25.37
Chandelier Exit (Long, 3 ATRs ) 1.82
Chandelier Exit (Short, 3 ATRs ) 1.96
Upper Bollinger Band 2.14
Lower Bollinger Band 1.57
Percent B (%b) 0.28
BandWidth 30.72
MACD Line -0.12
MACD Signal Line -0.13
MACD Histogram 0.0066
Fundamentals Value
Market Cap 163.57 Million
Num Shares 94.5 Million
EPS -1.24
Price-to-Earnings (P/E) Ratio -1.39
Price-to-Sales 3.62
Price-to-Book 2.52
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.91
Resistance 3 (R3) 1.91 1.84 1.88
Resistance 2 (R2) 1.84 1.80 1.85 1.87
Resistance 1 (R1) 1.79 1.77 1.82 1.79 1.86
Pivot Point 1.72 1.72 1.74 1.73 1.72
Support 1 (S1) 1.67 1.68 1.70 1.67 1.60
Support 2 (S2) 1.60 1.65 1.61 1.59
Support 3 (S3) 1.55 1.60 1.58
Support 4 (S4) 1.55